Faculty

Institution

Unit

Venue

James Abbruzzese

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

The University of Texas MD Anderson Cancer Center

NoneJames Abbruzzese is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

James Abbruzzese

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology cancer research pancreatic cancer tumor biology pharmacology cancer biology medicinal research cancer treatment cancer care clinical research radiation oncology surgical oncology oncogenes medicine molecular biology cancer discovery cancer cells carcinogenesis cancer genetics cancer management molecular cancer gastrointestinal oncology vascular biology cancer immunotherapy tumor targeting cellular therapy cancer genomics tumor microenvironment hepatology colorectal cancer cancer risk thoracic oncology cancer imaging pharmacotherapy phase ii study hepatocellular carcinoma anti-cancer agents advanced pancreatic cancer leukemia cancer growth liver cancer pancreatic surgery phase ii trial clinical investigation clinical radiation oncology disease progression novel therapies tumoral pathology cohort studies pancreatic adenocarcinoma gastrointestinal surgery drug trials therapeutic efficacy radiation therapy cancer prevention enzyme inhibition tumor suppressors pancreatic ductal adenocarcinoma tumor heterogeneity cell regulation clinical evidence apoptosis genitourinary cancers metastatic colorectal cancer pancreatic cancer cells advanced pancreatic adenocarcinoma preoperative chemoradiation solid tumors clinical outcome signaling pathways field trial neoadjuvant chemoradiation human pancreatic cancer neoadjuvant therapy advanced rectal cancer case-control study

Notable Scholarly Works

Notable Federal Grants

Collaborators

Use of an Ultra-Sensitive Sequencing Platform to Detect Mutant Kras in the Whole Blood of Pancreatic Cancer Patients.. Journal of Clinical Oncology (2025)

Abstract B021: Development of an Ultrasensitive Sequencing Platform for Blood-Based Mutation Profiling of Pancreas Cancer Patients. Cancer Research (2024)

Ryne RamakerJames AbbruzzeseChris Counter

molecular diagnosticsultrasensitive sequencing platformblood-based mutation profilingcancer researchpancreas cancer patientsmolecular biologynext-generation sequencing

Abstract C004: A Window-Of-Opportunity Trial Using Neoadjuvant Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer: Interim Analysis of Safety and Feasibility. Cancer Research (2024)

Ethan S AgritelleyElishama N KanuJiayin BaoAshley A FletcherHolly SkinnerAdi MolvinStacy MurrayCharles Y KimBrendan ClineEric MastriaDavid Y JohnsonNicholas C DeVitoGerard C BlobeJames L AbbruzzeseErika J CrosbyAllison MartinNiharika B MettuPeter J AllenDaniel P Nussbaum

localized pancreas cancercancer researchinterim analysiswindow-of-opportunity trialcancer treatmenthealth sciences

Data From Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells is Mediated by Oxidative Stress. (2023)

Scott KopetzDonald P. LesslieNikolas A. DallasSerk I. ParkMarjorie JohnsonNila U. ParikhMichael P. KimJames L. AbbruzzeseLee M. EllisJoya ChandraGary E. Gallick

cancer biologyreactive oxygen speciespharmacologyinhibitory activitycarcinogenesiscolon carcinoma cellstumor biologycancer researchoxidative stressoncologysynergistic activityredox biologyfunctional selectivitymedicinal researchcancer cellsoncogenesmolecular biologyenzyme inhibitioncancer geneticspathology

Data From Synthetic Microrna Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells. (2023)

Naotake TsudaSatoshi IshiyamaYufeng LiConstantin G. IoannidesJames L. AbbruzzeseDavid Z. Chang

tumor suppressorscell biologygliomaslong non-coding rnatumor biologycancer researchbiomedical engineeringbrain tumor researchnon-coding rnacancer discoverytumor microenvironmentinduces late apoptosisnovel therapiestranscription (biology)synthetic micrornatumor targetingpancreatic tumor cellscell deathcancer cellsoncogenesmolecular biology

Phase 1 First-In-Human Study of Pf-07257876, a Novel Cd47/Pd-L1 Bispecific Checkpoint Inhibitor, in Patients With Pd-1/Pd-L1-Refractory and -NaïVe Advanced Solid Tumors.. Journal of Clinical Oncology (2023)

Benedito A. CarneiroHoward SafranJ. Thaddeus Thaddeus BeckOmid HamidAlexander I. SpiraPanos SavvidesMartin GutierrezYujie ZhaoJames L. AbbruzzeseJeffrey P. WardSaravut John WerohaLoleta D. HarrisSean KentWilliam PierceallAthanasia SkouraJenny ZhengKenneth Alan KernJacob Stephen ThomasRafael Santana-Davila

anti-cancer agentscancer researchradiation oncologyoncologyclinical therapeuticscancer carefirst-in-human studypharmacologycancer treatmentclinical researchpharmacotherapy

Supplementary Data From Tolfenamic Acid Enhances Pancreatic Cancer Cell and Tumor Response to Radiation Therapy by Inhibiting Survivin Protein Expression. (2023)

Santhi KonduriJimmie ColonCheryl H. BakerStephen SafeJames L. AbbruzzeseAla AbudayyehMd. Riyaz BashaMaen Abdelrahim

tumor biologysurvivin protein expressionradiation therapyoncologyradiation oncologycancer researchcancer biologytumor responsecell biologypancreatic cancerpharmacologysupplementary datamedicinal research

Comprehensive Genomic and Transcriptomic Characterization of Small Bowel Adenocarcinoma.. Journal of Clinical Oncology (2022)

Karan PandyaJoanne XiuAlex FarrellMichael J. OvermanAndreas SeeberJim AbrahamAnthony Frank ShieldsEmil LouJohn MarshallJames L. AbbruzzeseHeinz-Josef LenzWolfgang Michael KornPat Gulhati

computational genomicsgastroenterologycancer researchoncologymedical mycologysmall bowel adenocarcinomacancer carecomprehensive genomictranscriptomics technologycancer genomicsgeneticsdigestive diseasesgastrointestinal oncologygenomicstranscriptomic characterizationgenome biologyclinical mycologythoracic oncologymolecular biologyclinical researchhealth sciences

Differential Effects of Dietary Macronutrients on the Development of Oncogenic Kras-Mediated Pancreatic Ductal Adenocarcinoma. Cancers (2022)

Liang ZhuJuntao JiJianjia MaDan WangMuyun LiuJames DuRong ChenWei HouJames AbbruzzeseCraig LogsdonVincent YangYongde LuoWeiqin Lu

cancer biologypharmacologydietary macronutrientscarcinogenesistumor biologycancer researchoncologyclinical nutritioncancer carecancer riskhepatologycancer genomicsdifferential effectsradiation oncologymolecular cancerhealth sciencescancer imagingcancer growththoracic oncologycancer genetics

A Case Report of Microsatellite Instability (Msi)-High, Her2 Amplified Pancreatic Adenocarcinoma With Central Nervous System Metastasis. AME Case Reports (2021)

Nicholas C. DeVitoColm KelleherKyle C. StricklandJames AbbruzzeseCarey AndersBrent A. HanksJingquan JiaNiharika B. MettuMichael A. MorseMargot O’NeillHope UronisYousuf ZafarJohn H. Strickler

geneticscancer researchclinical case reportcancer biologycase studiespancreatic cancerpancreatic adenocarcinomacancer geneticsneurologyhealth sciencesmicrosatellite instability

1
2
3
4
5
57
10 / page

James Abbruzzese

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

The University of Texas MD Anderson Cancer Center

NoneJames Abbruzzese is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

James Abbruzzese

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Use of an Ultra-Sensitive Sequencing Platform to Detect Mutant Kras in the Whole Blood of Pancreatic Cancer Patients.. Journal of Clinical Oncology (2025)

Abstract B021: Development of an Ultrasensitive Sequencing Platform for Blood-Based Mutation Profiling of Pancreas Cancer Patients. Cancer Research (2024)

Ryne RamakerJames AbbruzzeseChris Counter

molecular diagnosticsultrasensitive sequencing platformblood-based mutation profilingcancer researchpancreas cancer patientsmolecular biologynext-generation sequencing

localized pancreas cancercancer researchinterim analysiswindow-of-opportunity trialcancer treatmenthealth sciences

Data From Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells is Mediated by Oxidative Stress. (2023)

Scott KopetzDonald P. LesslieNikolas A. DallasSerk I. ParkMarjorie JohnsonNila U. ParikhMichael P. KimJames L. AbbruzzeseLee M. EllisJoya ChandraGary E. Gallick

Data From Synthetic Microrna Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells. (2023)

Naotake TsudaSatoshi IshiyamaYufeng LiConstantin G. IoannidesJames L. AbbruzzeseDavid Z. Chang

anti-cancer agentscancer researchradiation oncologyoncologyclinical therapeuticscancer carefirst-in-human studypharmacologycancer treatmentclinical researchpharmacotherapy

Supplementary Data From Tolfenamic Acid Enhances Pancreatic Cancer Cell and Tumor Response to Radiation Therapy by Inhibiting Survivin Protein Expression. (2023)

Santhi KonduriJimmie ColonCheryl H. BakerStephen SafeJames L. AbbruzzeseAla AbudayyehMd. Riyaz BashaMaen Abdelrahim

Comprehensive Genomic and Transcriptomic Characterization of Small Bowel Adenocarcinoma.. Journal of Clinical Oncology (2022)

Karan PandyaJoanne XiuAlex FarrellMichael J. OvermanAndreas SeeberJim AbrahamAnthony Frank ShieldsEmil LouJohn MarshallJames L. AbbruzzeseHeinz-Josef LenzWolfgang Michael KornPat Gulhati

Differential Effects of Dietary Macronutrients on the Development of Oncogenic Kras-Mediated Pancreatic Ductal Adenocarcinoma. Cancers (2022)

Liang ZhuJuntao JiJianjia MaDan WangMuyun LiuJames DuRong ChenWei HouJames AbbruzzeseCraig LogsdonVincent YangYongde LuoWeiqin Lu

A Case Report of Microsatellite Instability (Msi)-High, Her2 Amplified Pancreatic Adenocarcinoma With Central Nervous System Metastasis. AME Case Reports (2021)

Nicholas C. DeVitoColm KelleherKyle C. StricklandJames AbbruzzeseCarey AndersBrent A. HanksJingquan JiaNiharika B. MettuMichael A. MorseMargot O’NeillHope UronisYousuf ZafarJohn H. Strickler

geneticscancer researchclinical case reportcancer biologycase studiespancreatic cancerpancreatic adenocarcinomacancer geneticsneurologyhealth sciencesmicrosatellite instability

1
2
3
4
5
57
10 / page